This inventor holds 8 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Scandinavian Biopharma Holding Ab. Active years: 2016-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Göteborg, SE (2016 - 2020)
- Gothenburg, SE (2020 - 2023)
Company Filing History:
Years Active: 2016-2025
Title: Innovations and Contributions of Inventor Joshua Tobias
Introduction
Joshua Tobias is a notable inventor based in Gothenburg, Sweden. He has made significant contributions to the field of biotechnology, particularly in vaccine development. With a total of 8 patents to his name, Tobias has demonstrated a commitment to advancing medical science.
Latest Patents
One of his latest patents is titled "Method for Increasing ETEC CS6 Antigen Presentation on Cell Surface and Products Obtainable Thereof." This innovative method involves increasing the presentation of ETEC CS6 antigen on a cell surface by contacting cells expressing the antigen with an aqueous solution containing 0.6-2.2 percent phenol by weight. This process enhances the antigen presentation by at least 100%. Additionally, the patent outlines a method for manufacturing a killed whole cell vaccine for immunization against CS6-expressing ETEC, along with the cells and vaccines obtainable through these methods.
Career Highlights
Throughout his career, Joshua Tobias has worked with several prominent companies in the biotechnology sector. Notably, he has been associated with Scandinavian Biopharma Holding AB and Gotovax AB. His work in these organizations has contributed to the development of innovative solutions in vaccine technology.
Collaborations
Tobias has collaborated with esteemed colleagues in his field, including Nils Carlin and Ann-Mari Svennerholm. These partnerships have further enriched his research and development efforts.
Conclusion
Joshua Tobias is a distinguished inventor whose work has significantly impacted vaccine development. His innovative methods and collaborations continue to pave the way for advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile